Role of ivabradine for anthracycline-induced cardiotoxicity: a meta-analysis
Abstract Purpose Anthracyclines are widely used anticancer agents but are limited by dose-dependent cardiotoxicity. Ivabradine selectively reduces heart rate without negative inotropy and may offer cardio protection in cancer patients, though its efficacy in anthracycline-induced cardiotoxicity (AIC...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2026-05-01
|
| Sarja: | Cardio-Oncology |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s40959-026-00491-1 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|